HopeStage
Back to all studies
TerminatedNCT02476708

A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia

Placebo comparisonAges 18–65United States
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Listed locations
New HavenSee all locations and recruitment

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 11, 2016
Recruitment status
Terminated
Enrollment listed in the registry
12
Sponsor
Yale University
Sponsor type
University
Study type
Other
Intervention type
DIETARY_SUPPLEMENT
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT02476708
Official title
Show the full official title

A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Terminated

New Haven

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies